MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Association of a new pathogenic variant of LRRK2 with modifying lysosomal genes in a family with Parkinson’s disease

    L. Vela-Desojo, M. Osuna-Lopez, C. Guerrero, A. Pascual, F. Palau, J. Hoenicka (Alcorcón, Spain)

    Objective: To characterize a Parkinson’s disease (PD) family with high recurrence of the disease. Background: Parkinson’s disease (PD) is a complex neurodegenerative disorder in which…
  • 2022 International Congress

    Genome-wide association study of Aβ, t-tau and p-tau in CSF in Parkinson’s disease

    H. Iwaki (Bethesda, USA)

    Objective: To investigate genetic contributions to the Alzheimer’s disease (AD) related cerebrospinal fluid (CSF) biomarkers in the patients with Parkinson’s disease (PD). Background: Aβ, t-tau…
  • 2022 International Congress

    Clinically interpretable severity estimation of facial expression impairment in Parkinson’s disease

    Y. Dushin, G. Morinan, G. Sarapata, J. O'Keeffe (London, United Kingdom)

    Objective: To develop a scalable and interpretable computer-vision based algorithm to measure the severity of facial impairment in Parkinson’s disease. Background: Neurological disorders frequently manifest…
  • 2022 International Congress

    Design of a prodromal screening study for subtypes in Parkinson’s Disease

    E. Schaeffer (Kiel, Germany)

    Objective: To follow-up prodromal Parkinson’s Disease (PD) subtypes in a longitudinal cohort study, validating new biomarkers and ethical guidelines for early detection of PD. Background:…
  • 2022 International Congress

    High preoperative gait variability is a prognostic predictor of gait and balance in Parkinson disease patients with deep brain stimulation

    JH. Shin, R. Yu, CY. Lee, KA. Woo, HJ. Chang, HJ. Kim, JH. Lee, B. Jeon (Seoul, Republic of Korea)

    Objective: To elucidate the objective biomarker for long-term outcome of STN DBS in PD patients, we investigated the value of pre-operative quantitative gait parameters for…
  • 2022 International Congress

    Plasma Alzheimer’s disease biomarkers and cognitive progression in Parkinson’s disease

    A. Pilotto, NJ. Ashton, A. Lupini, B. Battaglio, S. Gipponi, E. Cottini, I. Grossi, A. Salvi, G. de Petro, M. Pizzi, K. Blennov, M. Gonzalez, D. Aarsland, H. Zetterberg, A. Padovani (Brescia, Italy)

    Objective: To evaluate the relationship between plasma Alzheimer's disease biomarkers and cognitive progression in Parkinson's disease Background: Plasma phosphorylated tau (ptau) isoforms have been recently…
  • 2022 International Congress

    Motor and non-motor features of Parkinson’s disease in a large cohort of Gaucher’s disease patients

    E. Monfrini, I. Trezzi, MC. Malaguti, A. Tessitore, A. Barbato, P. Tirelli, F. Spagnolo, MD. Cappellini, E. Cassinerio, I. Motta, F. Carubbi, F. Nascimbeni, L. Borin, A. Di Fonzo (Milano, Italy)

    Objective: To investigate the prevalence of PD motor and non-motor clinical features and to characterize the prodromal phase of PD in a cohort of GD…
  • 2022 International Congress

    Automatic Speech Recognition for speech therapy in a Parkinson’s disease patient

    A. Nuzzi (Bari, Italy)

    Objective: The aim of the present study was to examine the Automatic Speech Recognition (ASR) technology as a useful approach to enhance the speech intelligibility…
  • 2022 International Congress

    Incidental Lewy Body disease and idiopathic Parkinson’s disease: from common pathogenic factors to the overlapping clinical features

    E. Sansa, T. Warner, E. Depablo Fernandez (London, United Kingdom)

    Objective: To compare established early symptoms and risk factors associated with Parkinson’s disease (PD) in a cohort of incidental Lewy Body disease (iLBD) and healthy…
  • 2022 International Congress

    Impact of the delayed diagnosis in the prognosis of Parkinson’s disease.

    E. Ichikawa-Escamilla, AJ. Hernández-Medrano, P. Bazán-Rodríguez, E. Reséndiz-Henríquez, GI. Cerda-Hernández, MA. Ruíz-Mafud, RA. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To evaluate the difference of motor and non-motor dysfunction, and quality of life in Parkinson’s disease (PD) patients with and without delayed diagnosis. Background:…
  • « Previous Page
  • 1
  • …
  • 474
  • 475
  • 476
  • 477
  • 478
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley